Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease
Feature
Spotlight on Advancements in Mitral Valve Repair, Research

You may not know Carol Barr, but in the future, she could save your life. 


Barr’s death at 39 from sudden cardiac ...

Home January 24, 2024
Home
Data from non-randomized cohort confirms dramatic improvement in diuretic response and at least 95% reduction in loop diuretic requirements up to almost four months after last DSR therapy
News | Heart Failure
Sequana Medical Announces DSMB Approval to Start Randomized MOJAVE Cohort

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home January 23, 2024
Home
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
News | Cardiovascular Business
Three Researchers Awarded $1 million Each to Study New Heart Disease Treatments, Causes

January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods ...

Home January 22, 2024
Home
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
News | Cardiovascular Business
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)

January 22, 2024 — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently ...

Home January 22, 2024
Home
Sumeet Chugh, MD, shown at work in his Cedars-Sinai laboratory
News | Sudden Cardiac Arrest
Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award

January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-Sinai ...

Home January 19, 2024
Home
Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.
News | Heart Failure
Cardiac Dimensions Appoints Satya Shreenivas, MD, as Chief Medical Officer

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

Home January 16, 2024
Home
Pilot program to deploy highly portable technology to be rolled out later this year 
News | Artificial Intelligence
Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same ...

Home January 16, 2024
Home
Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.
News | Artificial Intelligence
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

Home January 15, 2024
Home
Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.
News | Stroke
Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

Home January 15, 2024
Home
Study in American Journal of Critical Care finds allowing patients to eat a heart-healthy diet prior to cardiac catheterization posed no safety risk, improved their satisfaction
News | Catheter
Fasting Before Cardiac Catheterization May Be Unnecessary

January 4, 2024 — The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of ...

Home January 04, 2024
Home
Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.
News | Heart Valve Technology
Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a know-how agreement with Mayo Clinic on the development of a cardiac clinical AI solution with the intent to prevent premature deaths from heart disease and stroke.
News | Artificial Intelligence
K Health to Collaborate with Mayo Clinic on Cardiac Clinical Artificial Intelligence (AI) Solution

January 4, 2024 — Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a ...

Home January 03, 2024
Home
Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.
News | Cardiovascular Clinical Studies
Cardionomic Announces Enrollment Completion in the STIM-ADHF and STOP-ADHF Pilot Studies

January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of ...

Home January 03, 2024
Home
Richard Kitsis, MD
News | Cardiovascular Business
Ohio State's Heart and Vascular Center Names 2023 Schottenstein Prize Laureate

December 27, 2023 — The Ohio State University Wexner Medical Center’s Heart and Vascular Center has named Richard Kitsis ...

Home December 27, 2023
Home
Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
News | Patient Monitors
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now